Literature DB >> 15338205

One-year follow-up of orthopaedic implants in HIV-positive patients.

W J Harrison1, C B D Lavy, C P Lewis.   

Abstract

We followed prospectively 38 orthopaedic implants in 36 HIV-positive patients. X-rays and clinical examination were used to assess union, and observation was made for early and late wound sepsis for 12 months from the time of surgery. Two patients died of causes unrelated to the implantation, two patients had implants removed for reasons other than infection and eight cases were lost to follow-up. Of the 26 cases that were reviewed at 1 year, no late sepsis was identified. All of the fractures, non-unions, osteotomies and arthrodeses united. The literature indicates that late sepsis following arthroplasty occurs more frequently in haemophiliacs who are HIV positive than their HIV-negative counterparts. It is still not certain whether or not such a risk also applies to HIV-positive patients who are not haemophiliacs and have undergone internal fixation of fractures or non-unions. This study increases the confidence that fixation in immune-compromised patients with intact skin is safe, at least for the time period that the implant is required. Further studies are required to know whether or not fixation implants should be removed.

Entities:  

Mesh:

Year:  2004        PMID: 15338205      PMCID: PMC3456908          DOI: 10.1007/s00264-004-0592-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  13 in total

1.  Surgery in high-HIV incidence poor countries.

Authors:  J Cairns
Journal:  Trop Doct       Date:  2000-01       Impact factor: 0.731

2.  Orthopaedic surgery and HIV disease in Africa.

Authors:  J E Jellis
Journal:  Int Orthop       Date:  1996       Impact factor: 3.075

3.  Late infection after total hip replacement.

Authors:  E M Downes
Journal:  J Bone Joint Surg Br       Date:  1977-02

4.  Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts < or = 200/mm3.

Authors:  M V Ragni; L S Crossett; J H Herndon
Journal:  J Arthroplasty       Date:  1995-12       Impact factor: 4.757

5.  Human Immunodeficiency Virus Infection: Complications and Outcome of Orthopaedic Surgery.

Authors: 
Journal:  J Am Acad Orthop Surg       Date:  1996-11       Impact factor: 3.020

6.  Orthopaedic procedures and prognosis in hemophilic patients who are seropositive for human immunodeficiency virus.

Authors:  W B Greene; L T DeGnore; G C White
Journal:  J Bone Joint Surg Am       Date:  1990-01       Impact factor: 5.284

7.  Postoperative infections in asymptomatic HIV-seropositive orthopedic trauma patients.

Authors:  G D Paiement; R A Hymes; M S LaDouceur; R A Gosselin; H D Green
Journal:  J Trauma       Date:  1994-10

8.  A growing spectrum of surgical disease in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. Experience with 120 major cases.

Authors:  N A Diettrich; J C Cacioppo; G Kaplan; S M Cohen
Journal:  Arch Surg       Date:  1991-07

9.  Wound healing after implant surgery in HIV-positive patients.

Authors:  W J Harrison; C P Lewis; C B D Lavy
Journal:  J Bone Joint Surg Br       Date:  2002-08

10.  The prevention of orthopaedic implant and vascular graft infections.

Authors:  C J Strachan
Journal:  J Hosp Infect       Date:  1995-06       Impact factor: 3.926

View more
  3 in total

1.  Fracture-related infections in HIV infected patients: A systematic review and meta-analysis.

Authors:  Luan Nieuwoudt; Reitze N Rodseth; Leonard Charles Marais
Journal:  J Orthop       Date:  2020-01-30

2.  Complications and surgical treatment after pathological fracture associated to HIV secondary disease. A case report.

Authors:  Jorge Fuentes-Sánchez; Enrique Gómez-Barrena
Journal:  J Surg Case Rep       Date:  2022-06-10

Review 3.  Fracture management in HIV positive individuals: a systematic review.

Authors:  Maheshi P C Wijesekera; Simon Matthew Graham; David Griffith Lalloo; Hamish Simpson; William J Harrison
Journal:  Int Orthop       Date:  2016-09-21       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.